

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | p38 MAPK ↓ ↑ | p38α ↓ ↑ | p38β ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMS-582949 |
+++
p38 MAPK, IC50: 13 nM |
98% | |||||||||||||||||
| Adezmapimod | 99%+ | ||||||||||||||||||
| Pexmetinib | ✔ | Tie-2 | 99%+ | ||||||||||||||||
| Skepinone-L |
++++
p38α, IC50: 5 nM |
98% | |||||||||||||||||
| Doramapimod |
++++
p38α, IC50: 38 nM p38α, Kd: 0.1 nM |
99%+ | |||||||||||||||||
| VX-702 | 99%+ | ||||||||||||||||||
| Ralimetinib dimesylate |
++++
p38α, IC50: 7 nM |
98% | |||||||||||||||||
| SB 202190 |
++
p38α, IC50: 50 nM |
++
p38β, IC50: 100 nM |
99%+ | ||||||||||||||||
| Losmapimod |
++++
p38α, pKi: 8.1 |
+++
p38β, pKi: 7.6 |
99%+ | ||||||||||||||||
| Neflamapimod |
+++
p38α, IC50: 10 nM |
+
p38β, IC50: 220 nM |
99%+ | ||||||||||||||||
| PH-797804 |
++
p38α, IC50: 26 nM |
+
p38β, IC50: 102 nM |
99% | ||||||||||||||||
| TAK-715 |
++++
p38α, IC50: 7.1 nM |
+
p38β, IC50: 0.20 μM |
99%+ | ||||||||||||||||
| SB 239063 |
++
p38α, IC50: 44 nM |
++
p38β, IC50: 44 nM |
99%+ | ||||||||||||||||
| Pamapimod |
+++
p38α, IC50: 0.014 μM |
+
p38β, IC50: 0.48 μM |
98%+ | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Asiatic acid, a pentacyclic triterpene from Centella asiatica, exhibits anticancer activities, induces apoptosis in melanoma cells, and provides barrier protective effects in human aortic endothelial cells (HAEC). It also demonstrates anti-inflammatory properties by inhibiting TNF-α-induced endothelial barrier dysfunction and the NLRP3 inflammasome activation along with the NF-κB pathway. These actions result in significant inflammation reduction in rats and offer neuroprotection in rat spinal cord injury models[1][2][3][4][5]. |
| 体内研究 | Asiatic acid, administered via intragastric gavage at dosages ranging from 5 to 75 mg/kg once daily, has been found to effectively inhibit pelvic inflammatory disease (PID) in rats within a pathogen-induced disease model, demonstrating antioxidant and anti-inflammatory effects[3]. Asiatic acid, administered through intragastric injection at dosages of 30 mg/kg and 75 mg/kg once daily, exhibits neuroprotective effects on spinal cord injury (SCI) in rats by mitigating inflammation and oxidative stress[4]. |
| 体外研究 | Asiatic acid stabilizes the barrier against TNF-α by preserving the structure of adherens junctions (AJs) and preventing the redistribution of tight junctions (TJs)[2]. Asiatic acid at a concentration of 40 μM maintains the stability of F-actin and diphosphate-MLC at the cellular periphery, thereby inhibiting their reorganization triggered by TNF-α (10 ng/mL for 1 hour). Conversely, Asiatic acid, within the range of 10-30 μM over 6 hours, does not diminish F-actin aggregation[2]. Asiatic acid, at a concentration of 40 μM administered for 6 hours, maintains the network structure of cell-cell contact regions and counteracts the TNF-α-induced structural rearrangement of vascular endothelial (VE)-cadherin and β-catenin[2]. Nonetheless, Asiatic acid, when applied in doses ranging from 10 to 40 μM for a duration of 6 hours, does not exhibit any inhibitory effect on the increased endothelial cell permeability caused by cytochalasin D (5 μM for 15 minutes). It has been observed that Asiatic acid enhances the diphosphorylation of myosin light chain (MLC)[2]. |
| Concentration | Treated Time | Description | References | |
| LLC cells | 20, 40, 80 μM | 24 h | Asiatic acid inhibited LLC cell proliferation and induced apoptosis. | Acta Pharm Sin B. 2017 Jan;7(1):65-72. |
| H1299 cells | 20, 40, 80 μM | 24 h | Asiatic acid inhibited H1299 cell proliferation and induced apoptosis. | Acta Pharm Sin B. 2017 Jan;7(1):65-72. |
| A549 cells | 20, 40, 80 μM | 24 h | Asiatic acid induced apoptosis in A549 cells in a dose- and time-dependent manner, accompanied by mitochondrial membrane potential collapse and increased ROS generation. | Acta Pharm Sin B. 2017 Jan;7(1):65-72. |
| mouse mesangial cells (mMES) | 20 µM | 24 h | The combination of AA and NG showed insignificant cytotoxicity on mMES cells at 24h in vitro. | Int J Biol Sci. 2022 Aug 29;18(14):5489-5502. |
| mouse tubular epithelial cells (mTEC) | 20 µM | 24 h | AANG pre-treatment markedly upregulated Smad7 while significantly inhibiting AGE-induced Smad3 and NF-κB activation, thereby inhibiting collagen I and α-SMA expression in the mTEC in vitro. | Int J Biol Sci. 2022 Aug 29;18(14):5489-5502. |
| splenic NK cells | 10 μM | 24 h | Combined treatment with AA and NG increased IFN-γ and granzyme B production | Mol Ther. 2018 Sep 5;26(9):2255-2266. |
| bone marrow-derived NK cells | 10 μM | 24 h | AA restored TGF-β1-suppressed Smad7 expression and inhibited Smad3 phosphorylation | Mol Ther. 2018 Sep 5;26(9):2255-2266. |
| primary culture of rat embryo mesencephalic neurons | 20 μM | 24 h | AA reversed METH-induced TH expression reduction, inhibited ERK phosphorylation and NF-κB/STAT3 translocation, and reduced TNF-α and IL-6 secretion. | J Neuroinflammation. 2017 Dec 11;14(1):240. |
| murine microglial BV2 cell line | 20 μM | 24 h | AA inhibited METH-induced NF-κB/STAT3 translocation and JAK2/ERK phosphorylation, reducing TNF-α and IL-6 secretion. | J Neuroinflammation. 2017 Dec 11;14(1):240. |
| human dopaminergic neuroblastoma SH-SY5Y cell line | 1, 10, 20 μM | 24 h | AA significantly suppressed METH-induced TNFR expression and inhibited TNF-α and IL-6 secretion and mRNA expression. | J Neuroinflammation. 2017 Dec 11;14(1):240. |
| cardiac fibroblasts | 20μM | 24 h | AA attenuated Ang II-induced accumulation of collagen I and collagen III by activating AMPKα and suppressing mTOR and ERK signaling pathways. | Int J Biol Sci. 2016 May 25;12(7):861-71. |
| neonatal rat cardiac myocytes | 20μM | 24 h | AA inhibited Ang II-induced cardiomyocyte hypertrophy by activating AMPKα and suppressing mTOR/P70S6K/S6 and ERK signaling pathways. | Int J Biol Sci. 2016 May 25;12(7):861-71. |
| neonatal mouse cardiomyocytes | 2–50μM | 12 h | To evaluate the protective effects of AA on OGD cardiomyocytes, results showed that AA significantly increased cell viability and improved energy metabolism (increased ATP level and phosphocreatine/ATP ratio). | Acta Pharmacol Sin. 2022 Jun;43(6):1395-1407. |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6J mice | Lewis lung cancer xenograft model | Oral | 50 and 100 mg/kg | Once daily for 13 days | Asiatic acid significantly inhibited tumor volume and weight, accompanied by significant apoptosis of lung cancer cells. | Acta Pharm Sin B. 2017 Jan;7(1):65-72. |
| Dbb mice | Type-2 diabetic nephropathy model | Oral | 300 mg/kg | Once daily for 20 weeks | Preventive treatment significantly reduced the urinary albumin-to-creatinine ratio (UACR) and HbA1c levels in dbb mice, improved insulin sensitivity and glucose metabolism, and restored islet β-cell development. | Int J Biol Sci. 2022 Aug 29;18(14):5489-5502. |
| C57BL/6 mice | B16F10 melanoma and LLC lung carcinoma models | Intraperitoneal injection | 10 mg/kg | Daily for 27 days | Combined treatment with AA and NG significantly inhibited melanoma and lung carcinoma growth and enhanced NK cell-mediated anti-tumor immunity | Mol Ther. 2018 Sep 5;26(9):2255-2266. |
| C57/B6 mice | Aortic banding model | Oral | 10 or 30mg/kg | Daily for 7 weeks | AA attenuated pressure overload-induced cardiac hypertrophy and fibrosis by activating AMPKα and suppressing mTOR/P70S6K/S6 and ERK signaling pathways. | Int J Biol Sci. 2016 May 25;12(7):861-71. |
| Mice | Spinal cord injury model | Intraperitoneal injection | 550 μg/kg | Once daily for 3 days | To test whether SS-31 regulated cPLA2 partially through the MAPK-P38 signalling pathway | J Neuroinflammation. 2023 Jan 7;20(1):6 |
| Sprague-Dawley rats | Permanent and transient middle cerebral artery occlusion models | Intravenous injection | 75 mg/kg | Single dose, observed for 24 hours or 14 days | To evaluate the neuroprotective effects of Asiatic acid in multiple stroke models, results showed AA significantly reduced infarct volume, improved neurological outcomes, and protected mitochondrial function and inhibited MMP-9 induction and activity. | Stroke. 2012 Jun;43(6):1632-8 |
| C57BL/6 mice | Myocardial infarction model | Oral | 5–125 mg/kg | Once daily for 7 consecutive days | To evaluate the protective effects of AA on the myocardial infarction mouse model, results showed that AA significantly reduced infarct size, improved cardiac function, and promoted mitophagy and glycophagy. | Acta Pharmacol Sin. 2022 Jun;43(6):1395-1407. |
| Sprague-Dawley rats and ICR mice | Unilateral ureteral occlusion (UUO) model | Oral | Rats: 10 mg/kg; Mice: 15 mg/kg | Rats: once a day for 7 days; Mice: once a day for 3 days | Asiatic acid attenuates renal injury and fibrosis in the UUO model by promoting the production of the endogenous ligand 15d-PGJ2, which activates PPAR-γ | Acta Pharmacol Sin. 2020 Mar;41(3):373-382 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.05mL 0.41mL 0.20mL |
10.23mL 2.05mL 1.02mL |
20.46mL 4.09mL 2.05mL |
|
| CAS号 | 464-92-6 |
| 分子式 | C30H48O5 |
| 分子量 | 488.7 |
| SMILES Code | O=C([C@]12CC[C@@H](C)[C@H](C)[C@@]1([H])C3=CC[C@]4([H])[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@]5([H])CC[C@@]4(C)[C@]3(C)CC2)O |
| MDL No. | MFCD00238541 |
| 别名 | Dammarolic Acid; Asiantic acid; NSC 166063 |
| 运输 | 蓝冰 |
| InChI Key | JXSVIVRDWWRQRT-UYDOISQJSA-N |
| Pubchem ID | 119034 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 250 mg/mL(511.56 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1